Pseudomonas aeruginosa DSM 102273 is a mesophilic human pathogen that has multiple antibiotic resistances and was isolated from patient material.
antibiotic resistance mesophilic human pathogen| @ref 20215 |
Last LPSN update
2025-12-16 10:01:22 |
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 23675 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 23675 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 23675 | positive | growth | 37 | mesophilic |
| Test 1 | Test 2 | Test 3 | |
|---|---|---|---|
| @ref | 23675 | 23675 | 23675 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar |
| Incubation temperature | 37 | 37 | 37 |
| Oxygen condition | aerob | aerob | aerob |
| Manual_annotation | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Penicillin G | 0 | 0 | 0 |
| Oxacillin | 0 | 0 | 0 |
| Ampicillin | 0 | 0 | 0 |
| Ticarcillin | 0 | 0 | 0 |
| Mezlocillin | 0 | 0 | 0 |
| Cefalotin | 0 | 0 | 0 |
| Cefazolin | 0 | 0 | 0 |
| Cefotaxime | 0 | 0 | 0 |
| Aztreonam | 6 | 8-10 | 8-10 |
| Imipenem | 0 | 0 | 0 |
| Tetracycline | 14-16 | 10 | 10 |
| Chloramphenicol | 10 | 0 | 0 |
| Gentamycin | 0 | 0 | 0 |
| Amikacin | 8 | 10-12 | 10-12 |
| Vancomycin | 0 | 0 | 0 |
| Erythromycin | 0 | 0 | 0 |
| Lincomycin | 0 | 0 | 0 |
| Ofloxacin | 0 | 0 | 0 |
| Norfloxacin | 0 | 0 | 0 |
| Colistin | 18 | 16 | 16 |
| Pipemidic acid | 0 | 0 | 0 |
| Nitrofurantoin | 0 | 0 | 0 |
| Bacitracin | 0 | 0 | 0 |
| Polymyxin b | 18-20 | 16-18 | 16-18 |
| Kanamycin | 0 | 0 | 0 |
| Neomycin | 6 | 10 | 10 |
| Doxycycline | 10 | 8-10 | 8-10 |
| Ceftriaxone | 0 | 0 | 0 |
| Clindamycin | 0 | 0 | 0 |
| Fosfomycin | 30 | 26-28 | 26-28 |
| Moxifloxacin | 0 | 0 | 0 |
| Linezolid | 0 | 0 | 0 |
| Nystatin | 0 | 0 | 0 |
| Quinupristin/dalfopristin | 0 | 0 | 0 |
| Teicoplanin | 0 | 0 | 0 |
| Piperacillin/tazobactam | 6 | 6 | 6 |
| Test 1 | |
|---|---|
| @ref | 23675 |
| Medium | Müller-Hinton Agar |
| Incubation temperature | 30 |
| Oxygen condition | aerob |
| Manual_annotation | 1 |
| Inhibition zone diameter in mm | |
| Ampicillin | 0 |
| Oxacillin | 0 |
| Penicillin G | 0 |
| Aztreonam | 8-10 |
| Ticarcillin | 0 |
| Cefotaxime | 0 |
| Ceftazidime | 0 |
| Ceftriaxone | 0 |
| Cefiderocol | 32 |
| Piperacillin/Tazobactam | 6-8 |
| Imipenem | 0 |
| Meropenem | 0 |
| Ciprofloxacin | 0 |
| Levofloxacin | 0 |
| Moxifloxacin | 0 |
| Ofloxacin | 0 |
| Amikacin | 8 |
| Gentamicin | 0 |
| Tetracycline | 16-18 |
| Tigecycline | 0 |
| Teicoplanin | 8 |
| Vancomycin | 0 |
| Polymyxin B | 20-22 |
| Colistin sulphate | 18-20 |
| Clindamycin | 0 |
| Erythromycin | 0 |
| Fosfomycin | 20 |
| Kanamycin | 0 |
| Chloramphenicol | 10 |
| Linezolid | 0 |
| Nitrofurantoin | 0 |
| Quinupristin/Dalfopristin | 0 |
| Rifampicin | 6-8 |
| Trimethoprim-sulfamethoxazole (1:19) | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68368 | 27613 ChEBI | amygdalin | - | fermentation | from API 20E |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68368 | 29016 ChEBI | arginine | + | hydrolysis | from API 20E |
| 68368 | 16947 ChEBI | citrate | + | assimilation | from API 20E |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68368 | 17634 ChEBI | D-glucose | - | fermentation | from API 20E |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68368 | 16899 ChEBI | D-mannitol | - | fermentation | from API 20E |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20NE |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68368 | 30849 ChEBI | L-arabinose | + | fermentation | from API 20E |
| 68368 | 62345 ChEBI | L-rhamnose | - | fermentation | from API 20E |
| 68368 | 25094 ChEBI | lysine | - | degradation | from API 20E |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68368 | 28053 ChEBI | melibiose | + | fermentation | from API 20E |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | + | reduction | from API 20NE |
| 68368 | 18257 ChEBI | ornithine | - | degradation | from API 20E |
| 68368 | 30911 ChEBI | sorbitol | - | fermentation | from API 20E |
| 68368 | 17992 ChEBI | sucrose | - | fermentation | from API 20E |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68368 | 27897 ChEBI | tryptophan | - | energy source | from API 20E |
| 68369 | 16199 ChEBI | urea | - | hydrolysis | from API 20NE |
| 68368 | 16199 ChEBI | urea | + | hydrolysis | from API 20E |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68369 | arginine dihydrolase | + | 3.5.3.6 | from API 20NE |
| 68368 | arginine dihydrolase | + | 3.5.3.6 | from API 20E |
| 68368 | beta-galactosidase | - | 3.2.1.23 | from API 20E |
| 68369 | cytochrome oxidase | + | 1.9.3.1 | from API 20NE |
| 68368 | cytochrome oxidase | + | 1.9.3.1 | from API 20E |
| 68369 | gelatinase | - | from API 20NE | |
| 68368 | gelatinase | - | from API 20E | |
| 68368 | lysine decarboxylase | - | 4.1.1.18 | from API 20E |
| 68368 | ornithine decarboxylase | - | 4.1.1.17 | from API 20E |
| 68368 | tryptophan deaminase | - | 4.1.99.1 | from API 20E |
| 68369 | urease | - | 3.5.1.5 | from API 20NE |
| 68368 | urease | + | 3.5.1.5 | from API 20E |
| @ref | ONPG | ADH (Arg) | LDC (Lys) | ODC | CIT | H2S productionH2S | URE | TDA (Trp) | IND | Acetoin production (Voges Proskauer test)VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX | Nitrite productionNO2 | Reduction to N2N2 | MotilityMOB | Growth on MacConkey mediumMAC | OF-O | OF-F | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23675 | - | + | - | - | + | - | + | - | - | - | - | - | - | - | - | - | - | + | - | + | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Rutin/Sulfobutylether-beta-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection. | De Gaetano F, Pastorello M, Pistara V, Rescifina A, Margani F, Barbera V, Ventura CA, Marino A. | Pharmaceutics | 10.3390/pharmaceutics16020233 | 2024 | | |
| Phenotype | Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. | Riester O, Kaiser L, Laufer S, Deigner HP. | Adv Sci (Weinh) | 10.1002/advs.202308806 | 2024 | |
| Antibacterial Nanoassembled Calix[4]arene Exposing Choline Units Inhibits Biofilm and Motility of Gram Negative Bacteria. | Consoli GML, Granata G, Ginestra G, Marino A, Toscano G, Nostro A. | ACS Med Chem Lett | 10.1021/acsmedchemlett.2c00015 | 2022 | | |
| Efficacy of Two Moroccan Cistus Species Extracts against Acne Vulgaris: Phytochemical Profile, Antioxidant, Anti-Inflammatory and Antimicrobial Activities. | Bouabidi M, Salamone FL, Gadhi C, Bouamama H, Speciale A, Ginestra G, Pulvirenti L, Siracusa L, Nostro A, Cristani M. | Molecules | 10.3390/molecules28062797 | 2023 | | |
| Studies on the Accumulation of Secondary Metabolites and Evaluation of Biological Activity of In Vitro Cultures of Ruta montana L. in Temporary Immersion Bioreactors. | Szewczyk A, Marino A, Taviano MF, Cambria L, Davi F, Trepa M, Grabowski M, Miceli N. | Int J Mol Sci | 10.3390/ijms24087045 | 2023 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive131883.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License